logo

For the Inventor, By the Inventor

Loveland, OH, United States of America

Gene W Holbert

This inventor holds 6 USPTO granted patents, plus 3 CIPO patents. Top assignee: Merrell Dow Pharmaceuticals. Active years: 1986-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gene W Holbert. Retrieved from https://idiyas.com/inventor/gene-w-holbert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal6 out of 455 
 
Merrell Dow Pharmaceuticals
 patents

Years Active: 1986-1990

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 4954491 - Method of treatment using 18-cyanoprogesterone derivatives (1990-09-04),
2. 4920114 - 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as (1990-04-24),
3. 4910191 - 19-substituted progesterone derivatives useful as 19-hydroxylase (1990-03-20),
4. 4882322 - 3.beta.,17.beta.-hydroxy-substituted steroids and related steroidal (1989-11-21),
5. 4824974 - Synthesis for the preparation of 4-amino-4,5-dihydro-2-furancarboxylic (1989-04-25),
6. 4588825 - Intermediates for the synthesis of 4-amino-4,5-dihydro-2-furancarboxylic (1986-05-13),

Title: Gene W Holbert: Innovator in Pharmaceutical Treatments

Introduction

Gene W Holbert is a notable inventor based in Loveland, OH (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperaldosteronism and related disorders. With a total of 6 patents to his name, Holbert's work has had a meaningful impact on medical science.

Latest Patents

One of Holbert's latest patents is a method of treatment using 18-cyanoprogesterone derivatives. This invention is directed towards a method for treating hyperaldosteronism, which involves administering an appropriate 18-cyanopregnane to patients. Another significant patent involves 19-fluoro- and cyano-substituted 21-hydroxyprogesterone derivatives. These compounds are described as active 19-hydroxylase inhibitors and are useful as antihypertensive agents. The preparation of these compounds utilizes various synthetic pathways depending on the specific 19-substituted progesterone or related compound desired.

Career Highlights

Throughout his career, Gene W Holbert has worked with prominent companies such as Merrell Dow Pharmaceuticals and John O. Johnston. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Some of Holbert's notable coworkers include J O'Neal Johnston and Joseph P Burkhart. Their collaboration has contributed to the advancement of research and development in the field.

Conclusion

Gene W Holbert's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments. His patents reflect a deep understanding of complex biochemical processes and a dedication to enhancing patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…